The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer

The definitive characterization of common cancer stem cell (CSCs) subpopulations in breast cancer subtypes with distinct genotypic and phenotypic features remains an ongoing challenge. In this study, we have used a non-biased genome wide screening approach to identify transcriptional networks that m...

書誌詳細
主要な著者:	Walsh, CA, Akrap, N, Garre, E, Magnusson, Y, Harrison, H, Andersson, D, Jonasson, E, Rafnsdottir, S, Choudhry, H, Buffa, F, Ragoussis, J, Ståhlberg, A, Harris, A, Landberg, G
フォーマット:	Journal article
言語:	English
出版事項:	Public Library of Science 2020

類似資料

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.
著者:: Claire A Walsh, 等
出版事項: (2020-01-01)

Induction of resistance to neurotrophic tropomyosin‐receptor kinase inhibitors by HMGCS2 via a mevalonate pathway
著者:: Yasuhiro Kato, 等
出版事項: (2024-06-01)

Identification of Distinct Breast Cancer Stem Cell Populations Based on Single-Cell Analyses of Functionally Enriched Stem and Progenitor Pools
著者:: Nina Akrap, 等
出版事項: (2016-01-01)

Proteomics of cell‐free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer‐progressing properties
著者:: Anna Gustafsson, 等
出版事項: (2024-06-01)

Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion
著者:: Sara Rhost, 等
出版事項: (2018-11-01)

Expression of HMGCS2 and its correlation with clinopathological characteristics in bladder cancer
著者:: ZHU Shuai, 等
出版事項: (2021-12-01)

Inhibition of Lung Squamous Cancer Target HMGCS1 Promotes Cellular Ferroptosis
著者:: Yinyun NI, 等
出版事項: (2024-05-01)

Hmgcs2 is the hub gene in diabetic cardiomyopathy and is negatively regulated by Hmgcs2, promoting high glucose‐induced cardiomyocyte injury
著者:: Ying Wang, 等
出版事項: (2024-03-01)

Differentially expressed miRNAs in Luminal and Basal-like breast cancer
著者:: Ming-Juan ZHAO, 等
出版事項: (2021-06-01)

Mevalonate Metabolism in Cancer Stemness and Trained Immunity
著者:: Georg Gruenbacher, 等
出版事項: (2018-09-01)

Mevalonate metabolism governs cancer immune surveillance
著者:: Georg Gruenbacher, 等
出版事項: (2017-10-01)

The Effect of Hypoxic and Normoxic Culturing Conditions in Different Breast Cancer 3D Model Systems
著者:: Andreas Svanström, 等
出版事項: (2021-11-01)

Debottlenecking mevalonate pathway for antimalarial drug precursor amorphadiene biosynthesis in Yarrowia lipolytica
著者:: Monireh Marsafari, 等
出版事項: (2020-06-01)

HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells
著者:: Fat-Moon Suk, 等
出版事項: (2022-11-01)

The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
著者:: Borja Guerra, 等
出版事項: (2021-02-01)

Pathology-based deep learning features for predicting basal and luminal subtypes in bladder cancer
著者:: Zongtai Zheng, 等
出版事項: (2025-02-01)

Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features
著者:: Maria Carmen Leiva, 等
出版事項: (2023-12-01)

Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
著者:: Karoline Berger, 等
出版事項: (2021-02-01)

Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
著者:: Andy Göbel, 等
出版事項: (2020-07-01)

Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
著者:: Linyuan Xue, 等
出版事項: (2020-08-01)

Potential Role of HMGCS2 in Tumor Angiogenesis in Colorectal Cancer and Its Potential Use as a Diagnostic Marker
著者:: Kejian Zou, 等
出版事項: (2019-01-01)

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
著者:: Hoffmann Georg F, 等
出版事項: (2006-04-01)

Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis
著者:: Maria B. Padua, 等
出版事項: (2018-05-01)

Targeting HMGCS1 restores chemotherapy sensitivity in acute myeloid leukemia
著者:: Cheng Zhou, 等
出版事項: (2024-07-01)

A Luminous Precursor in the Extremely Bright GRB 230307A
著者:: S. Dichiara, 等
出版事項: (2023-01-01)

Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study
著者:: Humberto Parada, 等
出版事項: (2017-12-01)

Cellular organization and molecular differentiation model of breast cancer-associated fibroblasts
著者:: Susann Busch, 等
出版事項: (2017-04-01)

Immunohistochemical Evaluation of Basal and Luminal Markers in Bladder Cancer: A Study from a Single Institution
著者:: Anh Toan Do, 等
出版事項: (2024-12-01)

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
著者:: Vipulkumar Dadhania, 等
出版事項: (2016-10-01)

Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers.
著者:: Doris Kim, 等
出版事項: (2016-01-01)

Transcriptome analysis of basal and luminal tumor-initiating cells in ErbB2-driven breast cancer
著者:: Nicholas Borcherding, 等
出版事項: (2015-06-01)

HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis
著者:: Rui Zhu, 等
出版事項: (2024-12-01)

Liver HMGCS2 is critical in the maintenance of liver lipid homeostasis during fasting
著者:: Yunfeng Zhou, 等
出版事項: (2023-05-01)

Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis
著者:: Shaza Asif, 等
出版事項: (2022-07-01)

KLF13 suppresses the proliferation and growth of colorectal cancer cells through transcriptionally inhibiting HMGCS1-mediated cholesterol biosynthesis
著者:: Weilong Yao, 等
出版事項: (2020-06-01)

The mevalonate pathway in <it>C. Elegans</it>
著者:: Rauthan Manish, 等
出版事項: (2011-12-01)

Mevalonate Metabolism in Immuno-Oncology
著者:: Georg Gruenbacher, 等
出版事項: (2017-12-01)

Expression of housekeeping genes varies depending on mevalonate pathway inhibition in cancer cells
著者:: Nanami Irie, 等
出版事項: (2023-07-01)

NFYC-37 promotes tumor growth by activating the mevalonate pathway in bladder cancer
著者:: Zefu Liu, 等
出版事項: (2023-08-01)

Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer
著者:: Natalia Ricco, 等
出版事項: (2019-09-01)